Showing results (81-90 of 120) with videos related to
Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2017
A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid TumorsBirgit Geoerger, Franck Bourdeaut, Steven G DuBois, et al.Pediatric Blood & Cancer|April 16, 2021
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescenceMark W Kieran, Hubert Caron, Jeanette Falck Winther, et al.Cancer Research|June 30, 2020
Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of NeuroblastomaKonstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2010
Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1Hervé Rubie, Bruno De Bernardi, Mary Gerrard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2014
A phase I trial of AT9283 (a selective inhibitor of aurora kinases) in children and adolescents with solid tumors: a Cancer Research UK studyLucas Moreno, Lynley V Marshall, Andrew D J Pearson, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2005
Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group StudyGareth J Veal, Michael Cole, Julie Errington, et al.The Lancet. Oncology|July 6, 2017
From class waivers to precision medicine in paediatric oncologyAndrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 12, 2019
A Phase I and Pharmacokinetic Study of Oral Dabrafenib in Children and Adolescent Patients with Recurrent or Refractory BRAF V600 Mutation-Positive Solid TumorsMark W Kieran, Birgit Geoerger, Ira J Dunkel, et al.Blood Advances|April 14, 2020
Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736Andrew S Moore, Amir Faisal, Grace W Y Mak, et al.Radiology|May 19, 2011
Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group ProjectHervé J Brisse, M Beth McCarville, Claudio Granata, et al.Pageof 12